Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients

American Journal of Surgery

Volumn 196, Issue 4, 2008, Pages 500-504

  Ma, Aye Moe Thu ^a   Barone, Julie ^a   Wallis, Ashley E ^a   Wu, Nancy Jade ^a   Garcia, Luiza Baez ^a   Estabrook, Alison ^a   Rosenbaum Smith, Sharon M ^a   Tartter, Paul Ian ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Breast cancer; Breast neoplasm; Chemotherapy; Compliance; Hormonal therapy; Radiation therapy; Survival rate; Tamoxifen

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CLINICAL FEATURE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

AGE FACTORS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TAMOXIFEN;

EID: 52049093675     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2008.06.027     Document Type: Article

References (15)

1. Hand R., Sener S., Imperato J., et al. Hospital variables associated with quality of care for breast cancer patients. JAMA 266 (1991) 3429-3432
2. Foley K.L., Kimmick G., Camacho F., et al. Survival disadvantage among MedicAid-insured breast cancer patients treated with breast conserving surgery without radiation therapy. Breast Cancer Res Treat 101 (2007) 207-214
3. Truong P.T., Bernstein V., Lesperance M., et al. Radiation therapy omission after breast-conserving surgery is associated with reduced breast-specific survival in elderly women with breast cancer. Am J Surg 191 (2006) 749-755
4. Vinh-Hung V., and Verschraegen C. Breast conserving surgery with or without radiotherapy: Pooled analysis for risks of ipsilateral breast breast tumor recurrence and mortality. J Natl Cancer Inst 96 (2004) 15-21
5. Vinh-Hung V., Voordeckers M., Van de Steene J., et al. Omission of radiotherapy after breast conserving surgery: survival impact and time trends. Radiother Oncol 671 (2003) 147-158
6. Chang E., Glissmeyer M., Tonnes S., et al. Outcomes of breast cancer in patients who use alternative therapies as primary treatment. Am J Surg 192 (2006) 471-473
7. De Csepel J., Tartter P.I., and Gajdos C. When not to give radiation therapy after breast conservation surgery for breast cancer. J Surg Oncol 74 (2000) 273-277
8. Balasubramanian S.P., Murrow S., Holt S., et al. Audit of compliance to adjuvant chemotherapy and radiotherapy guidelines in breast cancer in a cancer network. Breast 12 (2003) 136-141
9. Landercasper J., Dietrich L.L., and Johnson J.M. A breast cancer review of compliance with National Comprehensive Cancer Network breast cancer guidelines. Am J Surg 192 (2006) 525-527
10. Bickell N.A., Wang J.J., Oluwole S., et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 24 (2006) 1357-1362
11. Gajdos C., Tartter P.I., Bleiweiss I., and Bernstein J. The consequence of undertreating breast cancer in the elderly. J Am Coll Surg 192 (2001) 698-707
12. Enger S.M., Thwin S.S., Buist D.S.M., et al. Breast cancer treatment of older women in integrated health care settings. J Clin Oncol 24 (2006) 4377-4383
13. Partridge A.H., Wang P.S., Winer E.P., and Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21 (2003) 602-606
14. Rosenow III E.C. Patients' understanding of and compliance with medications: the sixth vital sign. Mayo Clin Proc 80 (2005) 983-987
15. Early Breast Cacner Trialists' Collaborative Group. Tamoxifen for early breast cancer: An overview of the randomised trials. Lancet 351 (1998) 1451-1467